Potentiation of antitumor and antimetastatic activities of adriamycin by a novel N-alkylated dihydropyridine,AC394, and its enantiomers in colon cancer-bearing mice

 Purpose: We have previously shown that a series of N-alkylated 1,4-dihydropyridines potentiate the therapeutic efficacy of vincristine in vincristine-resistant P388 leukemia. The purpose of this study was to investigate the ability of one of the compounds, AC394, and its enantiomers to potentiate the antitumor activity of adriamycin against colon cancer cells in vitro and in vivo. Methods: The effects of AC394 on potentiation of adriamycin cytotoxicity and enhancement of its accumulation were evaluated using colon 26, HCT-15 and MCF-7 cells. Furthermore, the activities of AC394 and its enantiomers were compared. We also studied the combined effects of (+)-AC394 and adriamycin on subcutaneously (s.c.)-implanted and liver metastasis tumor models. Results: AC394 potentiated the cytotoxicity of adriamycin and enhanced its accumulation in colon cancer cells (colon 26 and HCT-15), which are known to express P-GP (P-glycoprotein) intrinsically. Enhancement of adriamycin accumulation by AC394 was found in s.c.-implanted colon 26 cells in vivo. Although both enantiomers of AC394 showed equal activity in vitro, (+)-AC394 was more effective than (−)-AC394 given orally. (−)-AC394 was found to be cleared more rapidly from the plasma than (+)-AC394. Thus, (+)-AC394 was evaluated for further study. Administration of (+)-AC394 significantly potentiated the antitumor activities of adriamycin in human colon cancer HCT-15 cells implanted s.c. Furthermore, in the liver metastasis model using colon 26 cells, a model completely resistant to adriamycin, the combination therapy of adriamycin with (+)-AC394 produced superior antitumor effects over adriamycin alone. Conclusions: A newly synthesized N-alkylated 1,4-dihydropyridine derivative, (+)-AC394, showed superior effects on the potentiation of adriamycin antitumor and antimetastatic activities in vivo. These results suggest that this combination may have therapeutic efficacy not only against primary colon cancers but also against metastatic liver cancer. Received: 19 June 1995/accepted: 6 December 1995     

Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma

Background MUC5AC represents a mucin peptide core expressed in normal gastric epithelia. Its presence in gastric carcinomas was previously described as a characteristic of gastric differentiation. Methods MUC5AC reactivity was investigated by immunohistochemistry and correlated with clinicopathological variables in a large series (n=200) of gastric carcinomas. Results A statistically significant association between MUC5AC positivity and parameters of cancer progression (pTNM staging and grading) could not be observed. However, MUC5AC exhibited correlations with certain subtypes of histopathological differentiation. A significant reduction of MUC5AC expression was evident in mucinous and undifferentiated carcinomas according to the World Health Organization classification, as well as in type III cancers according to the Goseki classification system. Furthermore, reduced MUC5AC reactivity (confined to up to 35% of the tumor area) was significantly correlated with an unfavorable prognosis of all patients in univariate and multivariate analysis. The same association could be observed in the subgroup of pTNM stage I patients (n=60). Conclusions A significant reduction of gastric differentiation as reflected by MUC5AC immunoreactivity represents a marker of worse survival probability in gastric cancer. Finally, reduced MUC5AC positivity defines a high-risk subgroup of pTNM stage I patients.     

A Biophysical Model of the Inner Hair Cell: The Contribution of Potassium Currents to Peripheral Auditory Compression

The term peripheral auditory compression refers to the fact that the whole range of audible sound pressure levels is mapped into a narrower range of auditory nerve responses. Peripheral compression is the by-product of independent compressive processes occurring at the level of the basilar membrane, the inner hair cell (IHC), and the auditory nerve synapse. Here, an electrical-circuit equivalent of an IHC is used to look into the compression contributed by the IHC. The model includes a mechanically driven transducer potassium (K⁺) conductance and two time- and voltage-dependent basolateral K⁺ conductances: one with fast and one with slow kinetics. Special attention is paid to faithfully implement the activation kinetics of these basolateral conductances. Optimum model parameters are provided to account for previously reported in vitro observations that demonstrate the compression associated with the gating of the transducer and of the basolateral channels. Without having to readjust its parameters, the model also accounts for the in vivo nonlinear IHC transfer characteristics. Model simulations are then used to investigate the relative contribution of the transducer and basolateral K⁺ currents to the nonlinear IHC input/output functions in vivo. The simulations suggest that the voltage-dependent activation of the basolateral currents compresses the DC potential for stereocilia displacements above approximately 5 nm. The degree of compression exceeds 2-to-1 and is similar for all stimulation frequencies. The AC potential is compressed in a similar way, but only for frequencies below 800 Hz. The simulations further suggest that the nonlinear gating of the transducer current is responsible for the expansive growth of the DC potential with increasing sound level (slope of 2 dB/dB) at low sound pressure levels.Both authors contributed equally to this work.     

Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain

Recent evidence indicates that neural stem cell properties can be found among a mammalian skin-derived multipotent population. A major barrier in the further characterization of the human skin-derived neural progenitors is the inability to isolate this population based on expression of cell surface markers. Our work has been devoted to purified human skin-derived stem cells that are capable of neural differentiation, based on the presence or absence of the AC133 cell surface marker. The enriched skin-derived AC133(+) cells express the CD34 and Thy-1 antigens. These cells cultured in a growth medium containing epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) proliferate, forming spheres, and differentiate in vitro into neurons, astrocytes, and rarely into oligodendrocytes. Single cells from sphere cultures initiated from human purified AC133(+) cells were replated as single cells and were able to generate new spheres, demonstrating the self-renewing ability of these stem cell populations. Brain engraftment of cells obtained from human purified AC133(+)-derived spheres generated different neural phenotypes: immature neurons and a most abundant population of well differentiated astrocytes. The AC133-derived astrocytes assumed perivascular locations in the frontal cortex. No donor-derived oligodendrocytes were found in the transplanted mouse brains. Several donor small, rounded cells that expressed endothelial markers were found close to the host vessel and near the subventricular zone. Thus, mammalian skin AC133-derived cells behave as a multipotent population with the capacity to differentiate into neural lineages in vitro and, prevalently, endothelium and astrocytes in vivo, demonstrating the great plasticity of these cells and suggesting potential clinical application.     

Yessotoxin,a novel phycotoxin,activates phosphodiesterase activity. Effect of yessotoxin on cAMP levels in human lymphocytes

Yessotoxin (YTX) is a novel phycotoxin with an unknown mechanism of action that has been reported as cardiotoxic, when injected, but non-toxic if ingested orally. In this paper, we studied the effect of YTX on adenosine 3',5'-cyclic monophosphate (cAMP) pathway, since this pathway can be a cellular target to this toxin as happens in other diarrhetic toxins. We determined cAMP levels by enzymeimmunoassay and by using the cAMP dye recombinant fluorescein- and rhodamine-labeled protein kinase A, which increases their fluorescence when cAMP levels are increased. In the presence of YTX, and after a transient small increase, cAMP levels were decreased. This effect was Ca(2+) dependent since in a Ca(2+)-free medium YTX increased cAMP levels, but this event was reverted after addition of external calcium. YTX also reverted the increase of cAMP induced by the adenylyl cyclase activator forskolin. These variations in fluorescence units were confirmed when cAMP levels were measured by enzymeimmunoassay, YTX decreases cAMP from 52.81+/-3.66 to 44.53+/-4.5 fmol. Phosphodiesterase (PDE) IV inhibitors, rolipram or etazolate, did not modify the effect of YTX, however, when PDE IV was first inhibited no effect of YTX was observed. On the other hand, the PDE III inhibitor milrinone counteracted the effect of YTX, and a similar effect was observed with the unspecific PDE I inhibitor chlorpromazine. These results point to an effect of YTX on PDE activity. In the presence of YTX, the fluorescent PDE substrate Mant-cAMP, increased its rate of hydrolysis, the same as the PDE from bovine brain increased the hydrolysis of cAMP substrate. In addition, YTX increased interleukin-2 production, which indirectly confirms a decrease in cAMP. Although results show a very complex pattern of responses, due to the interactions and crosstalks between many systems, results suggest that YTX is a PDE activator in the presence of external Ca(2+).     

Molecular analysis of acid ceramidase deficiency in patients with Farber disease

Farber disease is a rare, autosomal recessively inherited sphingolipid storage disorder due to the deficient activity of lysosomal acid ceramidase, leading to the accumulation of ceramide in cells and tissues. Here we report the identification of six novel mutations in the acid ceramidase gene causing Farber disease: three point mutations resulting in single amino acid substitutions, one intronic splice site mutation resulting in exon skipping, and two point mutations also leading to occasional or complete exon skipping. Of interest, these latter two mutations occurred in adjacent nucleotides and led to abnormal splicing of the same exon. Expression of the mutated acid ceramidase cDNAs in COS-1 cells and subsequent determination of acid ceramidase residual enzyme activity demonstrated that each of these mutations was the direct cause of the acid ceramidase deficiency in the respective patients. In contrast, two known polymorphisms had no effect on acid ceramidase activity. Metabolic labeling studies in fibroblasts of four patients showed that even though acid ceramidase precursor protein was synthesized in these individuals, rapid proteolysis of the mutated, mature acid ceramidase occurred within the lysosome.     

Distribution of respiratory mucin proteins in human nasal mucosa

OBJECTIVES/HYPOTHESIS: The upper respiratory tract is involved in many acute and chronic respiratory tract diseases that present with the symptom of mucus hypersecretion. Mucin genes that encode for the backbone of glycoproteins contribute to the viscoelastic property of airway mucus. We examined the cellular expression and distribution of two major respiratory mucus-forming glycoproteins, MUC5AC and MUC5B, in normal human nasal tissues. METHODS: Immunohistochemical analysis using polyclonal antibodies against the mucins MUC5AC and MUC5B was performed in normal human nasal tissues. RESULTS: An abundant staining of submucosal mucus gland and epithelial goblet cells for MUC5B was found. Immunohistochemical analysis of MUC5AC showed staining of surface epithelium goblet cells, whereas there was no staining of glandular cells. Comparison of the expression to lower airways revealed a similar pattern of expression of both mucins. CONCLUSIONS: The data in the present study demonstrated the localization of the two major respiratory mucin proteins in human nasal mucosa with a similar distribution of expression of MUC5AC and MUC5B in normal upper and lower airways. Mucin protein expression parallels that of mucin messenger RNA expression.     

Latent ocular deviations in patients with advanced AIDS

The purpose of this study is to determine horizontal latent ocular deviations in patients with advanced AIDS (CD4+ count <0.050×10⁹/l) and to compare with normal values by means of the von Graefe technique. Twenty patients aged between 17 and 44 years with AIDS and aged-matched control groups were submitted to study. The AC/A ratio was also measured in both groups using the Gradient test. The AIDS patients showed a horizontal latent deviation value of 0.28 ± 1.07 exo at near (40 cm.) and 2.12 ± 1.37 eso at distance (6 m). The AC/A ratio obtained was 2.03 ± 0.65. Statistically significant differences were obtained in relation to aged-matched control group at near and at distance (p<0.01). The horizontal latent ocular deviation at near and at distance in advanced AIDS patients showed lower values than the expected. The AC/A relationship also was lower. The results obtained in this study indicate that AIDS patients suffer a divergence insufficiency, which could add to other visual complaints such as blurred vision, photophobia, nyctalopia and reading difficulty.     

Association Analysis of Common Genetic Variations in MUC5AC Gene with the Risk of Non-cardia Gastric Cancer in a Chinese Population

Several lines of evidence suggest that genetic variation in MUC5AC gene might contribute to the risk of gastriccancer. We conducted a case-control study to evaluate the relationship between common genetic variations inMUC5AC gene and non-cardia gastric cancer using an LD-based tagSNP approach in Baotou, north-westernChina. We genotyped 12 tagSNPs by TaqMan method among 288 cases with non-cardia gastric cancer and 281normal controls. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidenceintervals (CIs) for non-cardia gastric cancer risk in association with alleles, genotypes and haplotypes. Weobserved that the frequencies of rs3793964 C allele and rs11040869 A allele were significantly lower in cases thanin controls. Meanwhile, minor allele homozygotes of rs3793964 and rs11040869 were significantly associated witha decreased risk of non-cardia gastric cancer when compared with their major allele homozygotes. Furthermore,a statistically significantly protective effect of rs885454 genotypes on non-cardia gastric cancer was also observed(for CT vs. CC: OR=0.581, 95%CI=0.408-0.829; for CT/TT vs. CC: OR=0.623, 95%CI=0.451-0.884). Our resultsindicated that some common genetic variations in the MUC5AC gene might have effects on the risk of non-cardiagastric cancer in our studied population.